Eupraxia Pharmaceuticals Inc (EPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | EPRX | RGC | CTMX | ||
Company | Eupraxia Pharmaceuticals Inc | Regencell Bioscience Holdings Ltd | Cytomx Thera | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 2.94 | 6.03 | 1.0100 | ||
High | 2.97 | 6.25 | 1.0131 | ||
Low | 2.80 | 5.69 | 0.9361 | ||
Last | 2.82 | 5.92 | 0.9549 | ||
Change | -0.08 | -0.18 | -0.0451 | ||
% Change | -2.67% | -2.94% | -4.51% | ||
Volume | 1,905 | 23,699 | 501,728 | ||
20-Day Average Volume | 19,255 | 221,023 | 1,100,796 | ||
Previous Close | 2.90 | 6.10 | 1.0000 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 2.82 | 6.35 | 1.0313 | ||
20-Day Raw Stochastic | 44.59% | 18.94% | 5.70% | ||
20-Day Relative Strength | 55.09% | 48.81% | 37.84% | ||
Weighted Alpha | -9.86 | -91.49 | -65.65 | ||
Today's Opinion | 24% Buy | 40% Sell | 100% Sell | ||
Previous Opinion | 24% Buy | 40% Sell | 100% Sell | ||
Last Month's Opinion | 100% Sell | 72% Sell | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -7.61% since 11/08/24 | -12.14% since 11/08/24 | -12.84% since 11/08/24 | ||
Low | 2.78 on 11/13/24 | 5.69 on 11/15/24 | 0.9361 on 11/15/24 | ||
High | 3.35 on 11/11/24 | 7.36 on 11/11/24 | 1.1000 on 11/11/24 | ||
1-Month | |||||
%Chg | +22.22% since 10/15/24 | +12.18% since 10/15/24 | -15.18% since 10/15/24 | ||
Low | 2.31 on 10/22/24 | 4.58 on 10/24/24 | 0.9361 on 11/15/24 | ||
High | 3.79 on 11/01/24 | 12.50 on 10/28/24 | 1.1900 on 10/16/24 | ||
3-Month | |||||
%Chg | +14.23% since 08/15/24 | -31.30% since 08/15/24 | -20.17% since 08/15/24 | ||
Low | 2.20 on 10/14/24 | 4.18 on 10/08/24 | 0.9361 on 11/15/24 | ||
High | 3.79 on 11/01/24 | 12.50 on 10/28/24 | 1.3300 on 09/11/24 | ||
6-Month | |||||
%Chg | -0.34% since 05/15/24 | +16.75% since 05/15/24 | -51.53% since 05/15/24 | ||
Low | 2.20 on 10/14/24 | 3.03 on 07/22/24 | 0.9361 on 11/15/24 | ||
High | 3.79 on 11/01/24 | 32.44 on 07/23/24 | 2.0100 on 05/16/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 79,118 | 79,379 | 78,259 | ||
Shares Outstanding, K | 27,282 | 13,013 | 78,259 | ||
Annual Sales | 0 | 0 | 101,210,000 | ||
Annual Net Income | -28,220,000 | -4,300,000 | -570,000 | ||
Last Quarter Sales | 0 | N/A | 33,430,000 | ||
Last Quarter Net Income | -5,940,000 | N/A | 5,740,000 | ||
60-Month Beta | N/A | -0.60 | 1.06 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.17 on 11/07/24 | N/A | 0.07 on 11/07/24 | ||
Latest Earnings Date | 11/12/24 | 10/25/24 | 11/07/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | 02/15/18 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 5.94 |